Waverton Investment Management Ltd - Q3 2021 holdings

$2.54 Billion is the total value of Waverton Investment Management Ltd's 52 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .

 Value Shares↓ Weighting
TMO  Thermo Fisher Scientific COM US$1$8,170,000
+13.3%
14,3000.0%0.32%
+15.0%
LIVN  LivaNova plc Ord$5,565,000
-5.8%
70,2700.0%0.22%
-4.3%
PFE  Pfizer Inc Com US$0.05$2,500,000
+9.8%
58,1310.0%0.10%
+12.5%
MRK  Merck & Co Inc Com US$0.50$1,052,000
-3.4%
14,0000.0%0.04%
-2.4%
WRB  W R Berkley Corp Com US$0.20$767,000
-1.7%
10,4850.0%0.03%0.0%
RDSB  Royal Dutch Shell plc Sponsored ADR Class 'B' 0.07spon adr b$443,000
+14.2%
10,0000.0%0.02%
+13.3%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-10-18
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corporation Com US$0.000012542Q3 202311.0%
Apple Inc Com42Q3 20237.6%
Marsh & McLennan Cos Inc Com US$1.0042Q3 20235.6%
American Express Co Com US$0.2042Q3 20235.2%
Salesforce Inc Com USD0.00142Q3 20235.7%
Colgate-Palmolive Co Com US$1.0042Q3 20236.7%
Pfizer Inc Com US$0.0542Q3 20236.7%
Verizon Communications Inc42Q3 20232.4%
Exxon Mobil Corporation Com42Q3 20232.6%
Merck & Co Inc Com US$0.5042Q3 20230.1%

View Waverton Investment Management Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-08
13F-HR2024-02-09
13F-HR2023-11-06
13F-HR2023-08-02
13F-HR2023-04-27
13F-HR2023-02-02
13F-HR2022-10-19
13F-HR2022-07-13
13F-HR2022-04-26
13F-HR2022-02-07

View Waverton Investment Management Ltd's complete filings history.

Compare quarters

Export Waverton Investment Management Ltd's holdings